Endo launches Fortesta

CHADDS FORD, Pa. — Endo Pharmaceuticals has launched a recently approved testosterone gel for men.

Endo announced Thursday the launch of Fortesta, approved by the Food and Drug Administration for treating low testosterone — or low T — in men, which affects about 14 million men in the United States; around 1.3 million of those men currently are receiving treatment, according to Endo.

“We are excited to bring Fortesta gel to market in the United States and are confident that once men try it, Fortesta gel will quickly become a significant treatment option for many men with low T,” Endo COO Julie McHugh said.